Regenerative medicine and the gut.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Revolutionizing medicine: recent developments and future prospects in stem-cell therapy.International journal of surgery (London, England) · 2024
   Review
2. Biomaterials in Gastroenterology: A Critical Overview.Medicina (Kaunas, Lithuania) · 2019
   Review
3. Embracing change: striated-for-smooth muscle replacement in esophagus development.Skeletal muscle · 2016
   Review
4. A new era: endoscopic tissue transplantation.Current opinion in gastroenterology · 2013
   Review
5. Tissue engineering for neuromuscular disorders of the gastrointestinal tract.World journal of gastroenterology · 2012
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as